Clinical trials - Press Releases

Date	Title	Company
03-Oct-2023	Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and highly statistically significant proteinuria reduction in patients with IgA nephropathy (IgAN)	Novartis
29-Sep-2023	Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences	EmendoBio
29-Sep-2023	Eplontersen Phase III results published in JAMA showing consistent and sustained benefit at 35, 66 and 85-week analyses	AstraZeneca
28-Sep-2023	Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment	Quotient Sciences
26-Sep-2023	XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke	XBiotech Inc.
26-Sep-2023	4SC: Landmark RESMAIN study data presented at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting	4SC AG
26-Sep-2023	Dopavision Reports Successful Completion of Enrollment for MyopiaX-1 Trial	DopaVision
25-Sep-2023	palleos healthcare Advances Clinical Trial Execution with Veeva Vault Clinical Data Applications	Veeva Systems
25-Sep-2023	Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	AstraZeneca
22-Sep-2023	Veranova Welcomes Dr. William Sanders as Global VP of Chemical Development Operations	Veranova
22-Sep-2023	Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial	AstraZeneca
21-Sep-2023	Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011	Leucid Bio
21-Sep-2023	CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy	CellProthera
21-Sep-2023	SpyBiotech Announces MHRA Clinical Trial Application Filing for SPYVLP01	SpyBiotech
19-Sep-2023	Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth	Mural Health
19-Sep-2023	Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solution	Biofourmis
19-Sep-2023	Over 50’s back auto-enrolment in clinical trials tackling long-term health conditions	Lindus Health
19-Sep-2023	Panthera bucks the trend and brings vaccine trials to the UK	Panthera Biopartners
19-Sep-2023	ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development	ImmunOs Therapeutics
19-Sep-2023	1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)	1ST Biotherapeutics, Inc.